Tuya Smart Hosts Successful ‘Tuya Developer Day’ During CES 2025, Leading Industry Change with Innovative AI Technology
LAS VEGAS, Jan. 10, 2025 /PRNewswire/ — Tuya Smart (NYSE: TUYA, HKEX: 2391), a global cloud platform service provider, successfully hosted its highly anticipated Tuya Developer Day event during CES 2025. This year’s CES theme “DIVE IN” brought innovators, decision-makers, visionaries,…
Amrop, a Leading Global Executive Search and Leadership Consulting Firm, Announces New Office in Japan
BRUSSELS, Jan. 10, 2025 /PRNewswire/ — Amrop, a leading global executive search and leadership consulting firm, appoints JOMON Associates as its new team in Tokyo, marking the group’s re-entry in the Japanese market and adding significant coverage in the Asia Pacific region. Led by…
ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*
TAIPEI, Jan. 10, 2025 /PRNewswire/ — ASE Technology Holding Co., Ltd. (NYSE: ASX, TAIEX: 3711, “ASEH” or the “Company”), announces its revised unaudited consolidated net revenues for December, 4th quarter and full year of 2024. CONSOLIDATED NET REVENUES (UNAUDITED) Dec Nov Dec Sequential…
Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease Portfolio
HANGZHOU, China, Jan. 10, 2025 /PRNewswire/ — Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, today announced a licensing and collaboration agreement for the global development and…
Amrop, ein weltweit führendes Unternehmen für Executive Search und Leadership Consulting, kündigt ein neues Büro in Japan an
BRÜSSEL, 10. Januar 2025 /PRNewswire/ – Amrop, ein führendes globales Unternehmen für die Suche nach Führungskräften und die Beratung von Führungskräften, ernennt JOMON Associates zu seinem neuen Team in Tokio und markiert damit den Wiedereintritt der Gruppe in den japanischen Markt und…
Amrop, a Leading Global Executive Search and Leadership Consulting Firm, Announces New Office in Japan
BRUSSELS, Jan. 10, 2025 /PRNewswire/ — Amrop, a leading global executive search and leadership consulting firm, appoints JOMON Associates as its new team in Tokyo, marking the group’s re-entry in the Japanese market and adding significant coverage in the Asia Pacific region. Led by…
TECNO Debuts Groundbreaking Starry Optical Fiber Technology during CES 2025
TECNO launches an industry-first CMF technology that combines ultra-fine optical fibers with mini-LED lights into smartphone battery covers HONG KONG, Jan. 10, 2025 /PRNewswire/ — Innovative technology brand TECNO unveiled its first breakthrough of the year—Starry Optical Fiber…
SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA
SEOUL, South Korea, Jan. 10, 2025 /PRNewswire/ — SN BioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a Phase 1b/2 clinical trial. This achievement follows the designation of…
DAVE Investors Have Opportunity to Join Dave Inc. Securities Fraud Investigation with the Schall Law Firm
LOS ANGELES, Jan. 10, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dave Inc. (“Dave” or “the Company”) (NASDAQ: DAVE) for violations of the securities laws. The investigation…
RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Jan. 10, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutics, Inc. (“Revance” or “the Company”) (NASDAQ: RVNC) for violations of §§10(b) and 20(a) of the Securities…
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Jan. 10, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc. (“BioAge” or “the Company”) (NASDAQ: BIOA) for violations of the federal securities laws. Investors…
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Jan. 10, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. (“Regeneron” or “the Company”) (NASDAQ: REGN) for violations of §§10(b) and 20(a) of the…